chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm; feverish; achy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 70 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm"; PYREXIA (non-serious), outcome "unknown", described as "feverish"; PAIN (non-serious), outcome "unknown", described as "achy".  Additional information: This report for patient 1: Male, 70 years old. Caller stated "My wife and I experienced a sore arm, we felt feverish and achy with our two first doses of the Pfizer BioNTech COVID-19 vaccine. Caller is a consumer that was calling about the Pfizer Covid-19 vaccine adult dose. Caller mentions he has had all three doses and he is 70 years old. Him and his wife are fully boostered and they feel good.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
hospitalized 11/20/21-11/23/21, increased weakness, lethargy, increase work of breathing with activity, and vomiting
Hip problems,hip problem became critical,he was almost crippled; Unbearable pain; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Hip problems,hip problem became critical,he was almost crippled) and ARTHRALGIA (Unbearable pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Pain in hip.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced CONDITION AGGRAVATED (Hip problems,hip problem became critical,he was almost crippled) and ARTHRALGIA (Unbearable pain). At the time of the report, CONDITION AGGRAVATED (Hip problems,hip problem became critical,he was almost crippled) and ARTHRALGIA (Unbearable pain) was resolving.            No concomitant medication was provided. No treatment information was provided.   This case was linked to MOD-2021-322919 (Patient Link).
have  severe body aches/chills, 100.0 - 101. 0 fever all day  High fever started today at lunch time. Have been taking Tylenol / ibuprofen all day  I had Covid at the end of July 2020 along with pneumonia.  I STILL have the antibodies IGG and had been donating convalescent plasma.  Last Covid antibodies test on jan 25.  ( + ) pos IGG  I feel like I have Covid again!!!
Unusual sensation in my upper left arm region (the same shoulder where the vaccination was administrated) associated with weakness in the triceps and pectoral muscles during my workout. First started about a day before with some diffuse pain in the same shoulder blade area, which continued by now, when lately diminished.
This spontaneous report was received from a physician refers to a 10-year-old male patient. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were reported as "none". On 10-SEP-2012, the patient was administered a dose of VARIVAX via subcutaneous route for routine vaccinations (prophylaxis). Other suspect therapies included a dose of M-M-R II via subcutaneous route for prophylaxis and sterile diluent (dosage schedule was not reported). The physician reported that within few minutes of being administered these vaccines the patient had experienced anaphylactic reaction including blood pressure dropping and shortness of breath. The patient's mother reported to the physician that they had spent 6 hours in the doctor's office and then the patient was transported to an emergency room. The patient did not undergo any laboratory investigations. The patient sought medical attention. The patient was treated with Epinephrine (unknown dose/ manufacturer), steroids (unknown dose/ manufacturer) and antihistamines (unknown dose/ manufacturer). The patient was recovered on the same day. Causality of the event was not reported. The reporter considered the event anaphylactic reaction to be life threatening. Upon internal review the event anaphylactic reaction was considered as medically significant.
Patient was supposed to receive the PCV13 vaccination but incorrectly received the PPSV 23 vaccine. The patient had previously received the PPSV 23 vaccine on 1/24.24.
cellulitis at injection site; began 2 days post vaccination. observed for 24 hours (? delayed type hypersens) but erythema progressed (4x2 cm), developed petechiae in center, increased calor/tenderness; treated with minocycline 100 bid x 10 days. spoke with patient today (2 days post initiation of abx and lesion is now 1 cm in size and no longer swollen/tender).
Seen in our office 1/18/05. Received DTaP, HIB, IPV in left thigh. Mom brought back to office 1/20/05 for increasing swelling in left thigh. Admitted to hospital for cellulitis.
This case was reported by a pharmacist via call center representative and described the occurrence of eye red in a adult male patient who received SHINGRIX (batch number B5EK2, expiry date 28th April 2020). On an unknown date, the patient received SHINGRIX. On an unknown date, less than a day after receiving SHINGRIX, the patient experienced eye red, eye irritation, inadvertent exposure to vaccine, exposure via skin contact and exposure via eye contact. On an unknown date, the outcome of the eye red, eye irritation, inadvertent exposure to vaccine, exposure via skin contact and exposure via eye contact were unknown. The reporter considered the eye red and eye irritation to be related SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter was preparing the SHINGRIX product for administration. When he went to throw away the syringe that he had used to withdraw the adjuvant suspension, as he threw it, residual suspension splashed in his face and into his right eye, which led to inadvertent exposure to vaccine, exposure via skin contact and exposure via eye contact. He reported that his right eye was irritated and red in the outside corner.
Tested positive for COVID; Tested positive for COVID; This is a spontaneous report from a contactable consumer. This consumer reported events for three patients. This is the second of three reports. This report is for the son's friend.  A 21-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), first dose via an unspecified route of administration in 2021 (Batch/Lot number unknown) as a single dose; second dose via an unspecified route of administration in 2021 (Batch/Lot Number: Unknown) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. The patient got COVID after getting the Pfizer vaccine. The patient tested positive for COVID-19 in 2021. The consumer thinks the patient got the Pfizer one, but was not 100% sure.  It was about 4 months ago. The outcome of the events was unknown.  The lot number for BNT162B2, was not provided and will be requested during follow up.
Large swelling entire upper arm, pain radiating to my Left side breast and Left upper back. Left upper arm hot to touch, fever 24 hrs.
Skipped my upcoming period for an entire month including the PMS symptoms.  That has never happened since I?ve started my period as an adolescent. My periods have always been regular.
THE FIRST COUPLE DAYS AFTER THE VACCINE WAS GIVEN  THE PATIENT REPORTED REDNESS AT THE INJECTION SITE. AT DAY 5 AFTER THE VACCINE IT HAS BECOME MORE PURPLE/DARKER COLOR AT THE INJECTION SITE. IT IS ALSO WARM, TENDER TO TOUCH, AND ITCHY.
HIVES- FACE, NECK AND R FOREARM. HAD VACCINE ON 9/25 AT 1 PM. WOKE IN THE AM ON 9/26 WITH ITCHING AND HIVES. TAKING BENADRYL 25 MG Q 4 HRS WHILE AWAKE. STILL HAVE HIVES AS OF 9/29/2014.
shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was self-reported by the patient. The age at vaccination was not reported. The patient received 1st dose and had shingles. This case is linked with the case US2021AMR178318 and US2021AMR178307, reporter by the same reporter. For tolerance to the 2nd dose, refer the case US2021AMR194383.
urinary infection; pelvic pain; soreness in the abdominal area; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (urinary infection), PELVIC PAIN (pelvic pain) and ABDOMINAL PAIN (soreness in the abdominal area) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017E21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (urinary infection), PELVIC PAIN (pelvic pain) and ABDOMINAL PAIN (soreness in the abdominal area). At the time of the report, URINARY TRACT INFECTION (urinary infection), PELVIC PAIN (pelvic pain) and ABDOMINAL PAIN (soreness in the abdominal area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included asthma medication (inhalers).  No treatment medication was reported.  Scheduled for second dose on 17 Sep 2021 (but patient still had not gone).
I woke up this morning at 6 am with a 101.0 fever, body aches and head ache.  It went away after I took 600mg of Motrin, but came back 4 hours later.  I then took (2) 325 mgs of Tylenol, at 10 am and the fever broke at 10:30, but now at 1:28 I have another 101.0 fever and I just don't feel godod.
Approx. 2-3 weeks following the 5/12/98 MMR IZ, fine tremors were noted in both hands, lasting for brief periods (less than 30 seconds). Over the next few months the hand tremors become more noticeable lasting for longer periods of time, eventually becoming constant. By November, 5 months after the immunization, episodes of leg weakness developed resulting in slow ambulation and unexplained falling to the ground. By January, 7 months after the IZ, severe leg weakness developed manifested by ataxic gait and total body collapse with inability to get off the floor. Through out the year, his condition continued to rapidly deteriorate, resulting in the loss of function in both hands, both legs, voice, and oral muscle control resulting in excessive drooling. Approx. 15 months, post vax, he was wheel chair dependent, required total assistance with feeding, toileting, and mobility. Currently his level of function continues to decline with no reversal or improvement in symptoms. Although, he has had extensive  and extremely thorough medical evaluations by numerous physicians to determine the cause for this progressive demise in health and function, no medical dx has been made.
The shot was given on 3/14/2021.  At 1:45 am on  3/18/2021, I woke up with the area around my eyes itching and burning.  When I got up, my eyes were almost swollen shit.  The whole day of 3/18/2021, it felt like bees were stinging my eyes.  I did have the corona virus in December and my eyes reacted the same way at the end of my sickness.
Narrative: Patient received Moderna Covid #1 on 4/16/21 and #2 on 5/14/21. On 5/18/21, he was seen in the hematology clinic for IDA secondary to chronic blood loss from AVM and anemia due to CKD. At that time, he was in good spirits and was feeling well . On 6/7/21, he reported to our ER with c/o abd pain/diarrhea intermittently x 3 days. He was evaluated and discharged. On 6/9/21, he went to another ER with abdominal pain and was admitted. On 6/16/21, he underwent an exploratory lap with subtotal colectomy and ileostomy for an obstruction and was also noted to be on dialysis. His course was complicated with a UTI, septic shock and acute respiratory failure. On 6/23/21, family decided to withdraw care and he passed away that same day. Time from vaccine #2 until date of death was 40 days. No autopsy report available.
inadvertently got a dose of Bexsero during pregnancy; GC/CT 2/12/2020 +GC; Anemia; This prospective pregnancy case was reported by a nurse and described the occurrence of gonorrhea in a 18-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. The patient's last menstrual period was on an unknown date and estimated date of delivery was on an unknown date. The patient received Bexsero at an unknown time during the pregnancy. On an unknown date, unknown after receiving Bexsero, the patient experienced vaccine exposure during pregnancy. On an unknown date, the outcome of the vaccine exposure during pregnancy was unknown. The pregnancy was ongoing.  Additional details were provided as follows: The age at vaccination was not reported. The patient inadvertently got a dose of Bexsero during pregnancy, which led to vaccine exposure during pregnancy. The reporter did not know the patient was pregnant at the time. The reporter asked was there a secure way to do this.   Follow up information received from Nurse on 16th December 2020: The patient's demographic details were updated. The suspect batch number was updated. The VAERS details were updated. Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis and Flu Seasonal QIV Dresden(batch number 4MA5A) (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis.  The patient's past medical history included attention deficit hyperactivity disorder and obesity. Concurrent medical conditions included drug abuse.  On 11th February 2020, the patient received Bexsero (batch number ABXA14AB), Bexsero Pre-Filled Syringe Device and Influenza vaccine Quadrivalent 2019-2020 season. The patient's last menstrual period was on 16th October 2019 and estimated date of delivery was 22nd July 2020. The patient received Bexsero at week 15 of the pregnancy. On 12th February 2020, 1 days after receiving Bexsero, Bexsero Pre-Filled Syringe Device and Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced gonorrhea (serious criteria GSK medically significant) and anemia. On an unknown date, the outcome of the gonorrhea, anemia were unknown.  It was unknown if the reporter considered the gonorrhea and anemia to be related to Bexsero, Bexsero Pre-Filled Syringe Device and Influenza vaccine Quadrivalent 2019-2020 season.
numbing on lips; numbing on throat; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (numbing on lips) and PHARYNGEAL HYPOAESTHESIA (numbing on throat) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HYPOAESTHESIA ORAL (numbing on lips) and PHARYNGEAL HYPOAESTHESIA (numbing on throat). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA ORAL (numbing on lips) and PHARYNGEAL HYPOAESTHESIA (numbing on throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Itchy bumps like hives on different parts of the body including scalp, back, feet, hands, abdomen, back of neck and buttocks. Rash would pop up more in the evenings and move to different parts of the body. Would flare and go away in a matter of hours. Antihistamines helped.
I took the flu shot in my Rt arm and the following morning I had a bout of crippling Bursitis in my Rt leg. It still lingers today 5 days later.
A report was received from a consumer on 10/24/2003 concerning a 2 year old male vaccinee who inadvertently received Fluvirin on 10/17/2003. On 10/17/2003 the vaccinee, who was less than 4 years of age inadvertently received Flurvirin. The vaccinee did not experinece any untoward effects after receiving the Fluvirin. Update 1, 2/16/2004: A follow up report was received from a health care professional indicating that no adverse event had occurred at the time of reporting. There was insufficient information to determine the reporter's causality assessment. No follow up pending, all information received.
Severe swelling of both right and left eyelids. Had to take 6 doses of BENADRYL ALLERGY liquid gel caps 25mg. each.
This spontaneous report was received from a physician via a company representative, referring to a female patient of unknown age. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not reported. On 28-MAR-2017, the patient was vaccinated with GARDASIL 9, intramuscularly (lot number and expiration date were not provided) for prophylaxis. Other suspect therapies included diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid and MENACTRA. On the same date, while the patient was waiting in the physician office, she felt dizzy and faint. The patient continued to wait in the office, sipping water, until she was recovered. Furthermore, product quality issue was not involved. At the time of the report, the outcome of dizziness and syncope was reported as recovered. Additionally, the reporter did not provide for a causality between the adverse events and vaccination with GARDASIL 9. Additional information has been requested.
Employee exhibited right hip warmth and tightness  that radiated to her right jaw Narrative:
rash all over entire body poss secondary to polio/DTP vax given 15AUG95;whelps on abd;lung sounds rapid & coarse, no distress;diarrhea green & soupy
While getting vaccine, felt an electric like shock in left arm, with severe pain for 5 mins, and arm hanging limp. Pain resolved, with weakness, with symptoms improving for better daily.
Severe fatigue and body ache. High fever unable to treat at home. 102.8.
Expired vaccine was administered on 10/7/22 when it expired 09/30/22. According to manufacturer there is data to support extended stability thru 10/19/2022 for this LOT.
2 days after the second vaccination subconjunctive hemorrhage in right eye lasted 2+ weeks very painful, swollen behind  eye, draining blood.  Also joint pain increased exponentially in right side, inflammation in right foot
swelling on his face; swelling on his lips; developed inflammation on his neck; neck swelling; presented an allergic reaction; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date in 2021 as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient wants to know if he should receive the second dose of the vaccine, since on an unspecified date in 2021 after first dose, patient developed an allergic reaction and presented swelling on his face and lips from 4 to 6 hours after receiving the vaccine, later that night he developed inflammation on his neck, neck swelling, he never had anaphylaxis. Patient reported he had an appointment to receive the second dose on Thursday (31Mar2021), even though he wants to receive the second dose to be protected he might not receive it. Reporter stated response from PI, regarding contraindications included to not administer Pfizer-BioNTech COVID-19 Vaccine to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the Pfizer-BioNTech COVID-19 Vaccine; regarding warnings Appropriate medical treatment to be used to manage immediate allergic reactions must be immediately available in the event when an acute anaphylactic reaction occurs following administration of Pfizer-BioNTech COVID-19 Vaccine; the vaccine was approved as a two dose schedule, the first dose primes the immune system and the second one that boosts the immune system. No information on the efficacy of the first dose. The patient wants to know if he could use Epipen to counteract a severe allergic reaction to second dose of vaccine in case of presenting it. He also wants to know if there was any treatment on development for future allergic reactions due to vaccine also patient wants to know the protection percentage he would have with a single vaccine dose. Patient stated that there were some other patients who reported some symptoms the same as this. He was afraid with the second dose that it would give him a stronger reaction. Outcome of the events was unknown.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Rashes on body, hands and feet. itching so that couldn't sleep all night.  Sore on the arm at site of the injection. Still have the reaction at this time 9:00AM on 9/16/2012.
My last dose was bivalent but this site does not allow for multiple vaccinations/dates to be the potential source of the problem.  I am having signs of over active immune functions with autoimmune symptoms of hair loss, lichen sclerosus, joint pain and the like.  The hair loss worsened with time.  I have no way of knowing if its related to my covid vaccinations but thought I should report it.
high fever, delerious,went to the emergency room no symptoms at second day followup. Muscle spams - collapsed on floor, couldn't walk.  Still recovering.
Shortness of breath; Sleeplessness; Nausea; Panicky feeling; Headache; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 17Apr2021 at 13:00 (at the age of 46-year-old), as a single dose for COVID-19 immunisation. Medical history included reactive airway and high blood pressure. The patient was not aware of any allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and fluticasone propionate (FLOVENT); all for an unknown indication from unknown date and unknown if ongoing. On 18Apr2021, at 18:00, the patient experienced shortness of breath, sleeplessness, nausea, panicky feeling and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shortness of breath, sleeplessness, nausea, panicky feeling and headache was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.